马特林及其衍生物:癌症治疗中的多途径调节
1Department of Thoracic Surgery, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan Province, 646600, People's Republic of China.
Cancer management and research
|December 30, 2025
概括
在临床前模型中,Matrine衍生物显示出作为多向抗癌剂的前景,抑制瘤生长并克服抗药性. 需要进一步的研究来应对临床翻译的挑战.
科学领域:
- 自然产品化学 自然产品化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 马特林及其衍生物是具有多目标天然类化合物,已证明具有协同作用的抗瘤作用.
- 这些化合物调节关键的致癌途径,如Wnt/β-catenin,MAPK/ERK和PI3K/AKT/mTOR.
- 它们通过抑制表皮细胞-介质细胞转换 (EMT) 和诱导编程细胞死亡 (细胞亡,自,热亡) 来抑制瘤增殖.
研究的目的:
- 审查母体衍生物的抗瘤潜力.
- 突出其作用机制和临床前疗效.
- 确定临床翻译的挑战和未来方向.
主要方法:
- 在癌症治疗中对母体衍生物的临床前研究的审查.
- 分析它们对瘤致癌途径,细胞死亡和瘤免疫微环境的影响.
- 在患者衍生异种移植 (PDX) 模型中评估第三代衍生药物 (例如MT-26,YF-18).
主要成果:
- 第三代母蛋白衍生物在胰腺癌和肝癌PDX模型中显示出显著的瘤抑制 (60-78%).
- 这些衍生物向DNMT1/HDAC6双抑制,并激活NLRP3/caspase-1烧途径.
- 它们在克服化疗耐药性方面表现出有效性.
结论:
- 孕衍生物通过多途径调节和诱导细胞死亡,表现出强大的临床前抗癌活性.
- 包括低生物可用性,毒性和耐药性机制在内的挑战需要在临床应用中解决.
- 未来的战略包括先进的传递系统,精准医学和合成生物学,用于开发智能抗癌剂.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle
7.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K


